Medicare Enrolled

Dr. Karl Lautenschlager, M.D.

Pain Medicine · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5364 FREDERICKSBURG ROAD, San Antonio, TX 78229
2104414333
In practice since 2007 (18 years)
NPI: 1972708931 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lautenschlager from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lautenschlager? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lautenschlager

Dr. Karl Lautenschlager is a pain medicine specialist in San Antonio, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lautenschlager performed 4,434 Medicare services across 1,700 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lautenschlager received a total of $6,326 from 9 pharmaceutical and/or device companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lautenschlager is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 16% volume in TX $6,326 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,434
Medicare services
Top 16% in TX for pain medicine
1,700
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~246 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid) 1,041 $0 $11
Injection, propofol, 10 mg 855 $0 $18
Office visit, established patient (30-39 min) 518 $88 $363
Drug screening test 218 $60 $410
Steroid injection (triamcinolone) 218 $1 $5
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 208 $111 $447
Contrast dye for imaging, lower concentration 175 $0 $21
Office visit, established patient (20-29 min) 154 $59 $249
Injection, ketorolac tromethamine, per 15 mg 86 $0 $17
Injection, fentanyl citrate, 0.1 mg 85 $1 $26
Injection, methylprednisolone acetate, 80 mg 79 $9 $44
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance 77 $154 $1,842
Blood glucose (sugar) level 71 $4 $15
Betamethasone steroid injection 68 $5 $21
Injection, methylprednisolone acetate, 40 mg 62 $6 $27
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level 58 $201 $3,899
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level 38 $85 $1,417
Fluoroscopic guidance for needle placement 33 $88 $351
Injection of lower or sacral spine facet joint using imaging guidance, single level 32 $196 $6,524
Injection of lower or sacral spine facet joint using imaging guidance, second level 32 $105 $2,344
Joint injection, major joint 31 $51 $651
Injection of substance into lower spine canal using imaging guidance 31 $188 $2,488
Injection of upper or middle spine facet joint using imaging guidance, single level 30 $208 $5,903
Injection, midazolam hydrochloride, per 1 mg 30 $0 $16
Injection of upper or middle spine facet joint using imaging guidance, second level 28 $105 $2,488
New patient office visit (45-59 min) 28 $96 $503
Injection of substance into middle or upper spine canal using imaging guidance 26 $202 $2,637
Aspiration and/or injection of fluid large joint using ultrasound guidance 25 $78 $1,049
Injection of trigger points, 1-2 muscles 21 $39 $441
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint 19 $488 $9,595
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint 19 $268 $3,799
New patient office visit (30-44 min) 16 $81 $330
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint 11 $455 $9,162
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint 11 $267 $3,855
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,326
Total received (2018-2024)
Avg $904/year across 7 years
Top 35% in TX for pain medicine
9
Companies
96
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,326 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,430
2023
$172
2022
$1,455
2021
$463
2020
$477
2019
$630
2018
$1,698

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$2,085
Boston Scientific Corporation
$1,593
Relievant Medsystems, Inc.
$892
Medtronic USA, Inc.
$678
Nevro Corp.
$430
Medtronic, Inc.
$406
BOSTON SCIENTIFIC CORPORATION
$128
PAINTEQ LLC
$73
SPR Therapeutics, Inc
$42
Top 3 companies account for 72.2% of total payments
Associated products mentioned in payments ›
Axium INS DRG IPG · DRG IPGs · ETERNA · General - Pain Management · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · Neuromodulation Dspsbls and Accs · PAINTEQ · PROCLAIM · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · Senza Spinal Cord Stimulation System · Superion · Superion Indirect Decompression System · VANTA ADAPTIVESTIM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $143 per 100 Medicare services performed
Looking for a pain medicine specialist in San Antonio?
Compare pain medicines in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
32
Per 100K population
1.6
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lautenschlager is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lautenschlager experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Lautenschlager performed 1,041 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lautenschlager receive payments from pharmaceutical companies?
Yes. Dr. Lautenschlager received a total of $6,326 from 9 companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lautenschlager's costs compare to other pain medicines in San Antonio?
Dr. Lautenschlager's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lautenschlager) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →